Amyotrophic Lateral Sclerosis Clinical Trials in St Louis, Missouri

6 studies are recruiting for amyotrophic lateral sclerosis in St Louis, Missouri right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

   The goal of this clinical trial is to learn if the drug pridopidine works to treat amyotrophic lateral sclerosis in adults. It will also help to learn about the safety of pridopidine. The main question it aims to answer is: Does pridopidine slow disease progression of ALS? Researchers will compare …

   Stage

   Phase 3

   Ages

   18 to 80

   Site

   Washington University, St Louis, Missouri

   Locations

   55 in total

   Run by

   Prilenia

   See if you can join NCT07322003 on ClinicalTrials.gov

2. ASSESS ALL ALS Study

   The ALL ALS Clinical Research Consortium is establishing research to collect a wide range of samples, clinical information and measurements from Amyotrophic Lateral Sclerosis (ALS) symptomatic, ALS gene carriers and control cohorts. This consortium is being funded by the National Institutes of Heal…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Washington University, St Louis, Missouri

   Locations

   37 in total

   Run by

   St. Joseph's Hospital and Medical Center, Phoenix

   See if you can join NCT06578195 on ClinicalTrials.gov

3. PREVENT ALL ALS Study

   The ALL ALS Clinical Research Consortium is establishing research to collect a wide range of samples, clinical information and measurements from Amyotrophic Lateral Sclerosis (ALS) symptomatic, ALS gene carriers and control cohorts. This consortium is begin funded by the National Institutes of Heal…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Washington University, St Louis, Missouri

   Locations

   32 in total

   Run by

   St. Joseph's Hospital and Medical Center, Phoenix

   See if you can join NCT06581861 on ClinicalTrials.gov

4. ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

   ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) represents the formalized integration of ARTFL (U54 NS092089; funded through 2019) and LEFFTDS (U01 AG045390; funded through 2019) as a single North American research consortium to study FTLD for 2019 and beyond.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Washinton University in St. Louis, St Louis, Missouri

   Locations

   27 in total

   Run by

   Mayo Clinic

   See if you can join NCT04363684 on ClinicalTrials.gov

5. Intermuscular Coherence as a Biomarker for ALS

   The specific aims of this study are to: 1. Determine if a painless and quick measurement of muscle activity using surface electrodes can help with the diagnosis of ALS. Specifically, we ask if a measure of intermuscular coherence (IMC-βγ), when added to current diagnostic criteria (Awaji criteria),…

   Stage

   Not phased

   Ages

   20 to 90

   Site

   Washington University Medical Center, St Louis, Missouri

   Locations

   4 in total

   Run by

   University of Chicago

   See if you can join NCT05104710 on ClinicalTrials.gov

6. Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures

   The goal of the study is to generate a biorepository of longitudinal biofluids-blood (plasma and serum), cerebral spinal fluid (CSF) and urine linked to genetics and longitudinal clinical information that are made available to the research community. To accomplish these goals, we will enroll 800 Am…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Washington University, St Louis, Missouri

   Locations

   12 in total

   Run by

   Target ALS Foundation, Inc.

   See if you can join NCT05137665 on ClinicalTrials.gov